TMPRSS2 and prostate carcinoma: In that study, which aimed to investigate the role of TMPRSS2-ERG in NO-cGMP signaling in prostate cancer cells, silencing the sGCα1 gene expression was reported to decrease sGCβ1 protein levels without affecting its mRNA expression, and vice versa [45].